4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001741533-25-000003
CHIEF MEDICAL OFFICER sold 82,542 shares at $37.14 ($3,065,610)
- CHIEF MEDICAL OFFICER acquired 82,542 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Paolini John F. · CHIEF MEDICAL OFFICER
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-31 | Exercise or conversion : show line 1 in the form 10b5-1 | +36,542 | $3.80 | $138,860 | 97,866 | D |
| 2025-10-31 | Exercise or conversion : show line 2 in the form 10b5-1 | +46,000 | $8.83 | $406,180 | 143,866 | D |
| 2025-10-31 | Sale : show line 3 in the form 10b5-1 | −82,542 | $37.14 | $3,065,610 | 61,324 | D |
| Open-market sales · 82,542 sh · avg $37.14 · $3,065,610 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-31 | Exercise or conversion : show line 4 in the form 10b5-1 Share Option | −36,542 | 0 | D |
| 2025-10-31 | Exercise or conversion : show line 5 in the form 10b5-1 Share Option | −46,000 | 0 | D |
Loading xslF345X05/form4-11042025_091113.xml…